|
Volumn 30, Issue 5, 1998, Pages 1819-1821
|
Liver transplantation: Changing goals in immunosuppression
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
FINGOLIMOD;
IMMUNOSUPPRESSIVE AGENT;
MYCOPHENOLIC ACID;
STEROID;
TACROLIMUS;
CHRONIC ACTIVE HEPATITIS;
CONFERENCE PAPER;
DOSE RESPONSE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
ORAL DRUG ADMINISTRATION;
POSTOPERATIVE PERIOD;
PRIMARY BILIARY CIRRHOSIS;
PRIMARY SCLEROSING CHOLANGITIS;
PRIORITY JOURNAL;
CHILD;
CYCLOSPORINE;
GRAFT SURVIVAL;
HEPATITIS B;
HEPATITIS C;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
LIVER TRANSPLANTATION;
RECURRENCE;
SURVIVAL RATE;
TACROLIMUS;
|
EID: 0031664088
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00444-8 Document Type: Conference Paper |
Times cited : (6)
|
References (12)
|